Progress of chimeric antigen receptor T-cell therapy for treatment of acute myeloid leukemia

VernacularTitle:嵌合抗原受体T细胞治疗急性髓系白血病的研究进展
Author: Sijia YAN ¹ ; Yi XIAO
Author Information

1. 华中科技大学同济医学院附属同济医院血液内科，武汉　430030
Keywords: Leukemia, myeloid, acute; Chimeric antigen receptor T-cell; Molecular targeted therapy
From: Journal of Leukemia & Lymphoma 2025;34(7):438-441
CountryChina
Language:Chinese
Abstract: Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. Combination chemotherapy followed by hematopoietic stem cell transplantation is the preferred treatment option. Chimeric antigen receptor T-cell, as a rapidly developing cell therapy method, currently has no marketed products for the treatment of AML. This article reviews the research progress of chimeric antigen receptor T-cell therapy for the treatment of AML.